CENTRIENT PHARMACEUTICALS NETHERLANDS BV
CENTRIENT PHARMACEUTICALS NETHERLANDS BV (Netherlands) holds 7 active US FDA Type II Drug Master Files and 1 inactive, has DMF or CEP filings on record for 11 active ingredients and is linked to 4 FDA-registered manufacturing sites. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “CENTRIENT PHARMACEUTICALS NETHERLANDS BV: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/centrient-pharmaceuticals-netherlands-bv
Overview
CENTRIENT PHARMACEUTICALS NETHERLANDS BV is an active pharmaceutical ingredient (API) supplier with 7 active FDA Type II Drug Master Files, covering AMOXICILLIN TRIHYDRATE (PURIMOX); AMOXICILLIN TRIHYDRATE (PURIMOX®); ATORVASTATIN CALCIUM; CEFADROXIL MONOHYDRATE USP (PURIDROX ®); CEPHALEXIN MONOHYDRATE; NYSTATIN.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which CENTRIENT PHARMACEUTICALS NETHERLANDS BV holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
CENTRIENT PHARMACEUTICALS NETHERLANDS BV holds 7 active (8 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- ROSUVASTATIN CALCIUMActive2017-03-28
- ATORVASTATIN CALCIUMActive2015-08-03
- AMOXICILLIN TRIHYDRATE (PURIMOX)Active2012-03-16
- AMOXICILLIN TRIHYDRATE (PURIMOX®)Active2003-11-14
- CEFADROXIL MONOHYDRATE USP (PURIDROX ®)Active1998-09-01
- NYSTATINActive1998-09-01
- CEPHALEXIN MONOHYDRATEActive1998-04-30
- AMPICILLIN TRIHYDRATE (PURICILLIN)Inactive2012-10-30
Registered manufacturing sites (4)
Physical sites registered with the US FDA and resolved to CENTRIENT PHARMACEUTICALS NETHERLANDS BV, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
- CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITEDNawanshahr, India · API manufacture
- CENTRIENT PHARMACEUTICALS SPAIN S.A.SANTA PERPETUA DE MOGODA, Spain · API manufactureSite GMP match
- Deretil SACUEVAS DEL ALMANZORA ALMERIA, Spain · API manufactureSite GMP match
- Fersinsa GB, S.A. de C.V.Ramos Arizpe, Mexico · API manufacture
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to CENTRIENT PHARMACEUTICALS NETHERLANDS BV in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this CENTRIENT PHARMACEUTICALS NETHERLANDS BV?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.